340B in the Crosshairs: Pharma-Backed Ads Target Lawmakers Over Drug Discount Support

Nebraska Becomes a Leader in Protecting 340B Contract Pharmacies

Colorado’s 340B Expansion Bill Faces Pushback from Taxpayer Watchdogs

New Study Exposes Geographic Inequities in 340B Program Benefits

Ethical Considerations in 340B Program Management

Michigan’s Legislative Action to Protect 340B Contract Pharmacies

The Decline of U.S. Drugstores: What It Means for Underserved Communities

The Expanding Role of Pharmacy Technicians in Healthcare

Specialty Pharmacy vs. Retail Pharmacy: Key Differences and Trends

Pharmaceutical Companies Challenge 340B Rebate Rejections: What It Means for the Future of Drug Pricing

West Virginia’s 340B Law Blocked: What It Means for Pharmacies and Drug Pricing

Transparency and Consolidation Challenges in 340B Cancer Care

FDA’s Nicotine Reduction Initiative

Pharmacies’ Role Amid California Wildfires: Supporting Communities in Crisis

HHS Announces Next Steps in Medicare Part D Price Negotiations

The Future of Wearable Health Devices in Pharmacy

New 340B Rules on Contract Pharmacies: How to Navigate the Latest Changes

5 Tools Every Pharmacy Should Use to Optimize Operations

Collaborating with Community Pharmacies in the 340B Program

The Role of Blockchain in 340B: Ensuring Transparency and Accuracy in Drug Supply Chains

How AI is Revolutionizing 340B Compliance and Patient Matching

The Rise of Vertical Integration: What It Means for 340B Pharmacies

The Role of 340B in Expanding Access to Medications for Rural Communities

How 340B Processors Streamline Drug Pricing for Healthcare Providers

2024 340B Report

340B Myths vs. Facts: Clearing Up Common Misconceptions

How the 340B Program Benefits Patients

Understanding the 340B Drug Pricing Program